-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GDD-3898 in Obesity
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GDD-3898 in Obesity report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GDD-3898 in Obesity Drug Details: GDD-3898 is under development for the treatment of...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – GDD-3898 in Acne Vulgaris
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GDD-3898 in Acne Vulgaris report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GDD-3898 in Acne Vulgaris Drug Details: GDD-3898 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GDD-3898 in Dermatological Disorders
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GDD-3898 in Dermatological Disorders report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. GDD-3898 in Dermatological Disorders Drug Details: GDD-3898 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GDD-3898 in Non-Alcoholic Steatohepatitis (NASH)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GDD-3898 in Non-Alcoholic Steatohepatitis (NASH) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.GDD-3898 in Non-Alcoholic Steatohepatitis (NASH)Drug Details:GDD-3898 is under development for the treatment...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Blarcamesine Hydrochloride in Infantile Spasm (West Syndrome)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Blarcamesine Hydrochloride in Infantile Spasm (West Syndrome) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Blarcamesine Hydrochloride in Infantile Spasm (West Syndrome) Drug...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ASP-9801 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ASP-9801 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ASP-9801 in Solid Tumor Drug Details: ASP-9801 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SPI-62 in Polymyalgia Rheumatica (PMR)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SPI-62 in Polymyalgia Rheumatica (PMR) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.SPI-62 in Polymyalgia Rheumatica (PMR)Drug Details:Concomitant therapy of SPI-62 and next generation...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – GDD-3898
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry GDD-3898 Drug Details GDD-3898 is under development for the treatment of nonalcoholic fatty liver...
-
Product Insights
Prader-Willi Syndrome (PWS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Prader-Willi Syndrome (PWS) is a rare genetic disorder present at birth that results in several physical, mental, and behavioral problems. PWS is due to the lack of several genes on one of an individual’s two chromosome 15s. In most cases, there is a deletion. In remaining cases, the entire chromosome from the father is missing and there are instead two chromosome 15s from the mother (uniparental disomy). Symptoms include poor muscle tone, low levels of sex hormones, and a constant...